0 évaluation0% ont trouvé ce document utile (0 vote)
13 vues7 pages
Lupin is an Indian pharmaceutical company headquartered in Mumbai. In its fiscal year 2019 financial report:
1. Revenue increased 5.2% to Rs. 163,694 million compared to the previous year, but net profit declined due to lower margins and higher taxes.
2. New product launches in the US and other markets helped drive revenue growth. However, a provision for fines and lower gross margins decreased net profit margins.
3. The Board declared a dividend of 250% for shareholders for fiscal year 2019.
Lupin is an Indian pharmaceutical company headquartered in Mumbai. In its fiscal year 2019 financial report:
1. Revenue increased 5.2% to Rs. 163,694 million compared to the previous year, …